Nodexus
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $30M
Investors
- 2
About Nodexus
Nodexus Inc.Nodexus Inc. was founded in 2014 in Berkeley, US to develop advanced cell sorting and dispensing systems. The company has not pivoted in its core business strategy and operates without subsidiaries. It was co-founded by Karthik Balakrishnan and Vincent Tuminelli, with Karthik Balakrishnan serving as the CEO.Nodexus specializes in advanced cell sorting and dispensing systems, primarily focusing on the NX One and NX One MAX platforms. These systems utilize microfluidic technology designed for gentle cell sorting and single-cell dispensing, catering to disease research and drug discovery.Nodexus generates revenue through the sale of its NX One and NX One MAX cell sorting systems, along with associated microfluidic cartridges. The transaction structure is primarily B2B, engaging directly with research institutions and laboratories. The company is focused on launching new products and expanding into new markets, although specific new product launches and targeted regions have not been detailed.
Who invested in Nodexus
2 investors across 1 round
See all investors in Nodexus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 16, 2021
Amount
$30M
Investors
Questions about Nodexus
Who invested in Nodexus?
Nodexus has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nodexus raised?
Nodexus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nodexus last raise money?
Nodexus's most recent round on record is a Series A, in Dec 2021.
What does Nodexus do?
Nodexus is a biotechnology company.
Where is Nodexus headquartered?
Nodexus is headquartered in Berkeley, US.
Which VCs invest in companies like Nodexus?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nodexus's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nodexus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.